NMPA Clears IND for First T-Cell Receptor (TCR) T Cell Therapy to Treat Hepatitis B Virus (HBV) Associated Hepatocellular Carcinoma (HCC)
Singapore-based SCG Cell Therapy Pte Ltd ("SCG"), a leading biotechnology company, today announced that the China National Medical Products Administration...
